FORM 8-K: Current Report

As filed with the Securities and Exchange Commission on June 22, 2001

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of report (Date of earliest event reported)             June 19, 2001            


PHARMACIA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)


Delaware
(State or Other Jurisdiction of Incorporation)


1- 2516 43-0420020


(Commission File Number)


(IRS Employer Identification No.)


100 Route 206 North, Peapack, New Jersey 07977


(Address of Principal Executive Offices)


(Zip Code)


(908) 901-8000
(Registrant’s Telephone Number, Including Area Code)


N/A
(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Item 5.  Other Events.

             On June 19, 2001, the Registrant announced the resignation of John E. Robson from the Company’s Board of Directors following his recent appointment as Chairman and President of the Export-Import Bank of the United States. The Company also announced that the size of the Board was reduced to fourteen members.

             A copy of the press release issued by the Registrant on June 19, 2001 is attached hereto as Exhibit 99 and is hereby incorporated by reference herein.


Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

(c) Exhibits.

The following exhibit is filed as part of this Current Report on Form 8-K:

  99 Press Release of June 19, 2001.

 

 

 

SIGNATURES

             Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  PHARMACIA CORPORATION


Dated: June 22, 2001 By: /s/ Don W. Schmitz
   
    Name:
Title:
Don W. Schmitz
Vice President, Associate General
Counsel and Corporate Secretary

 

 

 

INDEX TO EXHIBITS



Exhibit No.

Exhibit

99 Press Release of June 19, 2001.